Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_assertion type Assertion NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_head.
- NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_assertion description "[Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experience.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_provenance.
- NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_assertion evidence source_evidence_literature NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_provenance.
- NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_assertion SIO_000772 20179708 NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_provenance.
- NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_assertion wasDerivedFrom befree-2016 NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_provenance.
- NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_assertion wasGeneratedBy ECO_0000203 NP795722.RAXWkrQx2COd2Lb6N0CYvkH3jMjMxNlKiXrWEGilgtJ7U130_provenance.